A thorough history and physical exam, supported by appropriate investigations, are essential to differentiate dementia from mild cognitive impairment and normal aging. It is important to consider the etiology of dementia syndrome because an estimated 11% to 14% of cases are caused by potentially reversible conditions.[11]Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988 Sep 15;109(6):476-86.
http://www.ncbi.nlm.nih.gov/pubmed/3046450?tool=bestpractice.com
[12]Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003 Oct 13;163(18):2219-29.
http://www.ncbi.nlm.nih.gov/pubmed/14557220?tool=bestpractice.com
A number of conditions can present in a similar way to dementia syndrome and must be considered during the evaluation. These include delirium, depression, amnestic syndromes, aphasia, and normal aging.
Modifiable lifestyle factors such as smoking, midlife obesity, a diet high in saturated fats, and consumption of >14 units of alcohol/per week have been associated with an increased risk for the development of dementia.[13]Lee Y, Back JH, Kim J, et al. Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr. 2010 Mar;22(2):174-87.
http://www.ncbi.nlm.nih.gov/pubmed/19883522?tool=bestpractice.com
[14]Ruan Y, Tang J, Guo X, et al. Dietary fat intake and risk of Alzheimer's disease and dementia: a meta-analysis of cohort studies. Curr Alzheimer Res. 2018;15(9):869-76.
http://www.ncbi.nlm.nih.gov/pubmed/29701155?tool=bestpractice.com
[15]Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024 Aug 10;404(10452):572-628.[16]Sabia S, Fayosse A, Dumurgier J, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ. 2018 Aug 1;362:k2927.
https://www.bmj.com/content/362/bmj.k2927.long
http://www.ncbi.nlm.nih.gov/pubmed/30068508?tool=bestpractice.com
Other potential risk factors include traumatic brain injury, hearing and vision loss, and high cholesterol.[15]Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024 Aug 10;404(10452):572-628.[17]Barnes DE, Byers AL, Gardner RC, et al. Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol. 2018 Sep 1;75(9):1055-61.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6143113
http://www.ncbi.nlm.nih.gov/pubmed/29801145?tool=bestpractice.com
[18]Loughrey DG, Kelly ME, Kelley GA, et al. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):115-26.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5824986
http://www.ncbi.nlm.nih.gov/pubmed/29222544?tool=bestpractice.com
[19]Cantuaria ML, Pedersen ER, Waldorff FB, et al. Hearing loss, hearing aid use, and risk of dementia in older adults. JAMA Otolaryngol Head Neck Surg. 2024 Feb 1;150(2):157-64.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10767640
http://www.ncbi.nlm.nih.gov/pubmed/38175662?tool=bestpractice.com
[20]Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017;56(1):215-28.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5240556
http://www.ncbi.nlm.nih.gov/pubmed/27911314?tool=bestpractice.com
[21]Hussain SM, Robb C, Tonkin AM, et al. Association of plasma high-density lipoprotein cholesterol level with risk of incident dementia: a cohort study of healthy older adults. Lancet Reg Health West Pac. 2024 Feb;43:100963.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10920036
http://www.ncbi.nlm.nih.gov/pubmed/38456089?tool=bestpractice.com
Prompt and thorough cognitive assessment quantifies the memory deficits and ensures appropriate diagnosis and management.[22]Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012 May-Jun;25(3):367-82.
http://www.jabfm.org/content/25/3/367.long
http://www.ncbi.nlm.nih.gov/pubmed/22570400?tool=bestpractice.com
[23]National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].
https://www.nice.org.uk/guidance/ng97
Drugs such as acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine) and memantine (an N-Methyl-D-Aspartate [NMDA] receptor antagonist) can temporarily improve dementia symptoms and slow cognitive impairment in some patients.[23]National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].
https://www.nice.org.uk/guidance/ng97
[
]
In people with Parkinson's disease dementia (PDD), Parkinson's disease cognitive impairment (CIND-PD), or dementia with Lewy bodies (DLB), what are the effects of cholinesterase inhibitors?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.71/fullShow me the answer
Mild cognitive impairment (MCI)
MCI is defined as a condition characterized by cognitive decline to an extent that is beyond that expected for age or educational background, yet not causing significant functional impairment.[24]Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16;90(3):126-35.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157
http://www.ncbi.nlm.nih.gov/pubmed/29282327?tool=bestpractice.com
MCI is conceptualized as a transitional state between the cognitive changes of normal aging and very early dementia.
Once the diagnosis of MCI is established, the next task is to identify the clinical subtype. There are two subtypes of MCI, amnestic and nonamnestic.[25]Petersen RC. Mild Cognitive Impairment. Continuum (Minneap Minn). 2016 Apr;22(2 dementia):404-18.
https://www.doi.org/10.1212/CON.0000000000000313
http://www.ncbi.nlm.nih.gov/pubmed/27042901?tool=bestpractice.com
Patients with memory impairment (taking into account age and education) have amnestic MCI. If memory is relatively spared, but the person has impairment in other nonmemory cognitive domains, such as language, executive function, or visuospatial skills, this constitutes nonamnestic MCI.[24]Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16;90(3):126-35.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157
http://www.ncbi.nlm.nih.gov/pubmed/29282327?tool=bestpractice.com
Patients with amnestic MCI typically progress to Alzheimer disease at a rate of 10% to 15% a year. These progression rates far exceed the population incidence figures for Alzheimer disease of 1% to 2% a year.[26]Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008 Jan;13(1):45-53.
http://www.ncbi.nlm.nih.gov/pubmed/18204414?tool=bestpractice.com
Degenerative and vascular
The majority of cases of dementia have degenerative and vascular causes.[10]Goodman RA, Lochner KA, Thambisetty M, et al. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement. 2017 Jan;13(1):28-37.
https://www.doi.org/10.1016/j.jalz.2016.04.002
http://www.ncbi.nlm.nih.gov/pubmed/27172148?tool=bestpractice.com
More than one cause may be contributing to the dementia syndrome.
Degenerative causes
Include Alzheimer disease (the most common cause of dementia accounting for an estimated 60% to 70% of cases), Lewy body disease, Parkinson disease, frontotemporal atrophy with and without Pick bodies, Huntington disease, progressive supranuclear palsy, and spinocerebellar degeneration.[27]Thal LJ, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology. 1988 Jul;38(7):1083-90.
http://www.ncbi.nlm.nih.gov/pubmed/3386827?tool=bestpractice.com
The disease entity limbic-predominant age-related TDP-43 encephalopathy (LATE) has been described.[28]Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 Jun 1;142(6):1503-1527.
https://www.doi.org/10.1093/brain/awz099
http://www.ncbi.nlm.nih.gov/pubmed/31039256?tool=bestpractice.com
LATE neuropathologic change (LATE-NC) is defined by a stereotypical TDP-43 proteinopathy in older adults, with or without coexisting hippocampal sclerosis pathology. It is associated with an amnestic dementia syndrome that mimicked Alzheimer-type dementia in retrospective autopsy studies, and is distinguished from frontotemporal lobar degeneration with TDP-43 pathology based on the relatively restricted neuroanatomical distribution of TDP-43 proteinopathy and its epidemiology (LATE generally affects older subjects).[28]Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 Jun 1;142(6):1503-1527.
https://www.doi.org/10.1093/brain/awz099
http://www.ncbi.nlm.nih.gov/pubmed/31039256?tool=bestpractice.com
Vascular causes
Account for 5% to 20% of dementia cases.[10]Goodman RA, Lochner KA, Thambisetty M, et al. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement. 2017 Jan;13(1):28-37.
https://www.doi.org/10.1016/j.jalz.2016.04.002
http://www.ncbi.nlm.nih.gov/pubmed/27172148?tool=bestpractice.com
[29]Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer's and vascular types. Biomed Res Int. 2014;2014:908915.
https://www.doi.org/10.1155/2014/908915
http://www.ncbi.nlm.nih.gov/pubmed/25089278?tool=bestpractice.com
Vascular dementia includes dementia due to multiple infarcts, a strategic single infarct, hemorrhage, hypoperfusion, delayed effects of irradiation, vasculitic disorders involving the central nervous system, cardiac disorders, and Binswanger disease.[30]Corey-Bloom J, Thal LJ, Galasko D, et al. Diagnosis and evaluation of dementia. Neurology. 1995 Feb;45(2):211-8.
http://www.ncbi.nlm.nih.gov/pubmed/7854514?tool=bestpractice.com
[31]Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies; report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250-60.
http://www.ncbi.nlm.nih.gov/pubmed/8094895?tool=bestpractice.com
[32]Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov;8(11):1006-18.
http://www.ncbi.nlm.nih.gov/pubmed/19782001?tool=bestpractice.com
Binswanger disease, also called subcortical vascular dementia, is caused by widespread, microscopic areas of damage to the deep layers of white matter in the brain. It is a pathologic diagnosis and a rare cause of vascular dementia.
Psychiatric
Psychiatric causes of memory problems include delirium, depression, and amnestic syndromes.
Dementia and depression may coexist, and depression increases the 5-year risk of institutionalization and death in people with dementia.[33]Okura T, Plassman BL, Steffens DC, et al. Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc. 2011 Mar;59(3):473-81.
https://www.doi.org/10.1111/j.1532-5415.2011.03314.x
http://www.ncbi.nlm.nih.gov/pubmed/21391937?tool=bestpractice.com
Over 25% of patients with neurodegenerative disorders receive a prior psychiatric diagnosis, most frequently depression. Patients with severe isolated memory loss have an increased risk of developing dementia and should be closely monitored.[34]Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-5.
http://www.ncbi.nlm.nih.gov/pubmed/9074575?tool=bestpractice.com
Patients with behavioral variant frontotemporal dementia are at highest risk for misdiagnosis.[35]Woolley JD, Khan BK, Murthy NK, et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011 Feb;72(2):126-33.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076589/?tool=pubmed
http://www.ncbi.nlm.nih.gov/pubmed/21382304?tool=bestpractice.com
Neoplastic
Neoplastic causes include metastatic lesions of the brain, primary brain tumors, primary meningeal tumors, and carcinomatosis.
Endocrinologic, metabolic, and nutritional deficiency
Related causes include vitamin B12 or folate deficiency, Cushing disease, hypopituitarism, parathyroid disease, porphyria, thyroid disease (hypo- or hyperthyroid state), uremia, and Wilson disease.
Traumatic
Causes include subdural hematoma and traumatic brain injury hypoxemic anoxia. Patients with head trauma may develop memory problems, although the link between head injury and dementia is controversial.[17]Barnes DE, Byers AL, Gardner RC, et al. Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol. 2018 Sep 1;75(9):1055-61.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6143113
http://www.ncbi.nlm.nih.gov/pubmed/29801145?tool=bestpractice.com
[36]Jellinger KA. Head injury and dementia. Curr Opin Neurol. 2004 Dec;17(6):719-23.
http://www.ncbi.nlm.nih.gov/pubmed/15542981?tool=bestpractice.com
[37]Nordström A, Nordström P. Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study. PLoS Med. 2018 Jan 30;15(1):e1002496.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790223
http://www.ncbi.nlm.nih.gov/pubmed/29381704?tool=bestpractice.com
After human brain injury, both amyloid beta peptide deposition and tau pathology (in which tau protein, a microtubule-associated protein, accumulates as neurofibrillary tangles and dystrophic neurites) are seen, even in younger patients.[38]Roberts GW, Gentleman SM, Lynch A, et al. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):419-25.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1072869
http://www.ncbi.nlm.nih.gov/pubmed/8163989?tool=bestpractice.com
[39]Takahata K, Kimura Y, Sahara N, et al. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. Brain. 2019 Oct 1;142(10):3265-79.
https://academic.oup.com/brain/article/142/10/3265/5556830
http://www.ncbi.nlm.nih.gov/pubmed/31504227?tool=bestpractice.com
Amyloid beta peptide levels in the cerebrospinal fluid and the overproduction of beta amyloid precursor protein in humans after traumatic brain injury are increased. Repeated head trauma in humans accelerates the amyloid beta peptide accumulation and cognitive impairment. Retrospective autopsy data support clinical studies suggesting that severe traumatic brain injury with long-lasting morphologic residuals are a risk factor for the development of dementia.[36]Jellinger KA. Head injury and dementia. Curr Opin Neurol. 2004 Dec;17(6):719-23.
http://www.ncbi.nlm.nih.gov/pubmed/15542981?tool=bestpractice.com
Infectious
Causes include Lyme disease, neurosyphilis, and tuberculosis meningitis. There has been an increase in cases of syphilis in low- and middle-income countries and in certain populations in developed countries in recent years, but the diagnosis of neurosyphilis tends to be overlooked because of its rarity.[40]Ropper AH. Neurosyphilis. N Engl J Med. 2019 Oct 3;381(14):1358-1363.
https://www.doi.org/10.1056/NEJMra1906228
http://www.ncbi.nlm.nih.gov/pubmed/31577877?tool=bestpractice.com
Creutzfeldt-Jakob disease (CJD) is a rare but fatal neurodegenerative disease caused by infectious proteins called prions. It is characterized by spongiform changes, neuronal loss, reactive astrocytic proliferation, and accumulation of pathologic cellular protein.[41]Spero M, Lazibat I. Creutzfeldt-Jakob disease: case report and review of the literature. Acta Clin Croat. 2010 Jun;49(2):181-7.
http://www.ncbi.nlm.nih.gov/pubmed/21086738?tool=bestpractice.com
CJD occurs in three general forms: sporadic or spontaneous, genetic or familial, and acquired (iatrogenic). A variant form of CJD (vCJD) is associated with eating meat from cattle affected by bovine spongiform encephalopathy. CJD is a rapidly progressive dementia, with death usually resulting from respiratory infection.[41]Spero M, Lazibat I. Creutzfeldt-Jakob disease: case report and review of the literature. Acta Clin Croat. 2010 Jun;49(2):181-7.
http://www.ncbi.nlm.nih.gov/pubmed/21086738?tool=bestpractice.com
Inflammatory
Causes include demyelinating diseases, lupus erythematosus, sarcoidosis, Sjogren syndrome, and limbic encephalitis.
Iatrogenic
Drug-related causes include use of antihistamines and anticholinergics.[42]Fox C, Smith T, Maidment I, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014 Sep;43(5):604-15.
http://ageing.oxfordjournals.org/content/43/5/604.long
http://www.ncbi.nlm.nih.gov/pubmed/25038833?tool=bestpractice.com
[43]Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018 Apr 25;361:k1315.
https://www.doi.org/10.1136/bmj.k1315
http://www.ncbi.nlm.nih.gov/pubmed/29695481?tool=bestpractice.com
[44]Coupland CAC, Hill T, Dening T, et al. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019 Jun 24;:.
https://www.doi.org/10.1001/jamainternmed.2019.0677
http://www.ncbi.nlm.nih.gov/pubmed/31233095?tool=bestpractice.com
Some authors report increased risk of dementia with use of benzodiazepines and other sedative/hypnotic drugs in a dose dependent fashion, but this needs further investigation.[45]Torres-Bondia F, Dakterzada F, Galván L, et al. Benzodiazepine and Z-drug use and the risk of developing dementia. Int J Neuropsychopharmacol. 2022 Apr 19;25(4):261-8.
https://academic.oup.com/ijnp/article/25/4/261/6417179
http://www.ncbi.nlm.nih.gov/pubmed/34727174?tool=bestpractice.com
[46]Ferreira P, Ferreira AR, Barreto B, et al. Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews. Eur Geriatr Med. 2022 Feb;13(1):19-32.
http://www.ncbi.nlm.nih.gov/pubmed/34403113?tool=bestpractice.com
[47]AlDawsari A, Bushell TJ, Abutheraa N, et al. Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022 Feb;88(4):1567-89.
https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15113
http://www.ncbi.nlm.nih.gov/pubmed/34679196?tool=bestpractice.com
[48]Brieler JA, Salas J, Amick ME, et al. Anxiety disorders, benzodiazepine prescription, and incident dementia. J Am Geriatr Soc. 2023 Nov;71(11):3376-89.
http://www.ncbi.nlm.nih.gov/pubmed/37503956?tool=bestpractice.com
There is some evidence that androgen deprivation therapy in men and estrogen-only hormone therapy in women may be associated with an increased risk of dementia; further investigation is required.[49]Jayadevappa R, Chhatre S, Malkowicz SB, et al. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer. JAMA Netw Open. 2019 Jul 3;2(7):e196562.
https://www.doi.org/10.1001/jamanetworkopen.2019.6562
http://www.ncbi.nlm.nih.gov/pubmed/31268539?tool=bestpractice.com
[50]Pourhadi N, Mørch LS, Holm EA, et al. Dementia in women using estrogen-only therapy. JAMA. 2024 Jan 9;331(2):160-2.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10728800
Toxic
Alcohol; heavy metals such as arsenic, lead, and mercury; histotoxic anoxia due to carbon monoxide; and cyanide are possible causes.[51]Bakulski KM, Seo YA, Hickman RC, et al. Heavy metals exposure and Alzheimer's disease and related dementias. J Alzheimers Dis. 2020;76(4):1215-42.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7454042
http://www.ncbi.nlm.nih.gov/pubmed/32651318?tool=bestpractice.com